P. Thédrez

发表

Comparative characteristics of 17-1A and GA-733 monoclonal antibodies for immunoscintigraphic application.

J. Douillard, J. Chatal, C. Curtet, 1986, Hybridoma.

Use of multi‐cell spheroids of ovarian carcinoma as an intraperitoneal radio‐immunotherapy model: Uptake, retention kinetics and dosimetric evaluation

J. Chatal, M. Bardiès, A. Faivre-Chauvet, 1992, International journal of cancer.

Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.

P. Fumoleau, J. Chatal, C. Curtet, 1989, Cancer research.

Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2002, Molecular cancer therapeutics.

Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.

J. Douillard, H. Koprowski, J. Chatal, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?

J. Chatal, A. Faivre-Chauvet, J. Gestin, 2004, European Journal of Nuclear Medicine.

In vitro therapeutic targeting of neuroblastomas using 125I‐labelled meta‐iodobenzylguanidine

H. Métivier, J. Chatal, R. Masse, 1990, International journal of cancer.

Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten.

F. Kraeber-Bodéré, E. Gautherot, J. Chatal, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.

J. Chatal, J. Gestin, J. Saccavini, 1989, Cancer research.

Immunoscintigraphy of recurrences of gynecologic carcinomas.

P. Fumoleau, J. Chatal, C. Curtet, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.

J. Chatal, G. Meinken, S. Srivastava, 1993, Nuclear medicine and biology.

Gd‐25 DTPA‐MAb, a potential NMR contrast agent for MRI in the xenografted nude mouse: Preliminary studies

J. Chatal, C. Tellier, S. Akoka, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Selective modification ofNMR relaxation timeinhumancolorectal carcinoma byusing gadoliniumdiethylenetriaminepent

J. Chatal, P. Thédrez, 1986 .

Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2007, International journal of pharmaceutics.

Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody

J. Chatal, D. Goldenberg, J. Barbet, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody

J. Chatal, C. Curtet, J. Vuillez, 2004, European Journal of Nuclear Medicine.

Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer

F. Kraeber-Bodéré, A. Mishra, J. Chatal, 1996, European Journal of Nuclear Medicine.

A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP)

A Lisbona, J. Barbet, M. Bardiès, 2007, Physics in medicine and biology.

A new tumor-associated antigen expressed on breast carcinomas, defined by monoclonal antibody BCA 227.

J. Douillard, J. Chatal, J. Aubry, 1991, Cancer research.

Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.

M Bardiès, R. Bataille, O. Couturier, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Comparative targeting of human colon‐carcinoma multicell spheroids using one‐ and two‐step (bispecific antibody) techniques

E. Gautherot, J. Chatal, J. Barbet, 1996, International journal of cancer.

The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody

J. Barbet, A. Faivre-Chauvet, E. Frampas, 2011, Nuclear medicine communications.

Monoclonal antibodies specific immunotherapy of gastrointestinal tumors.

J. Douillard, H. Blottière, J. Vignoud, 1986, Hybridoma.

Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies

J. Chatal, J. Saccavini, P. Lehur, 2004, European Journal of Nuclear Medicine.

Comparison between 131I and 111In as radiolabels for monoclonal antibodies in immunoscintigraphy of tumor bearing nude mice.

J. Douillard, J. Chatal, P. Thédrez, 1986, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Fragments of monoclonal antibodies specific to the presence of active white blood cells - their process of preparation and their application in the case of transplant rejection

J. Chatal, J. Soulillou, J. Paineau, 1989 .

Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination

J. Bénard, J. Chatal, Y. Jacques, 1994, International journal of cancer.

J. Barbet, A. Faivre-Chauvet, E. Frampas, 2011, Nuclear medicine communications.